Private Labs Are Suffering

The closure of an independent biomedical research institute near Boston has drawn attention to the similar predicament of other private labs that rely on federal grants.

By | November 21, 2012

Flickr, University of California DavisOver-reliance on shrinking federal research budgets led to the closure last week (November 15) of the Boston Biomedical Research Institute (BBRI) in Watertown, Massachusetts, a move that not only ended 44 years of biomedical research but also highlighted the similar struggles of independent research institutes across the United States.

“The BBRI could be a bellwether,” Jonathan Chernoff, chief scientific officer of the Fox Chase Cancer Center in Philadelphia—recently bought by Temple University—told Nature. “The same thing may befall other institutes, even the larger ones.”

Researchers in private labs are free from the teaching responsibilities that can weigh down those working at universities or hospitals. But by the same token, independent institutes don’t have the revenue from tuition fees or the administrative infrastructure to generate funds from elsewhere, so they rely more heavily on money from National Institutes of Health (NIH) grants for individual investigators—making them vulnerable to the continued economic downturn.

In the case of the BBRI, the figures tell the story. In 2010, it received $10 million in NIH grants—more than 80 percent of the institute’s entire budget. But by 2012, it received only $6.5 million in grant money, and projections for 2013 calculated in July came in at $3 million. In debt and unable to raise enough funds through other channels, the BBRI was forced to close its doors.

Faced with a similar situation, other private labs are laying off non-essential staff and aggressively seeking money from philanthropists. Some are trying to forge partnerships with pharmaceutical and biotech companies. For example, the Monell Chemical Senses Center in Philadelphia has built relationships with 50 companies, such that it relied on government grants for only 52 percent of its revenue in 2010.

But both of these funding strategies are fraught with challenges, so many independent research ventures fear the worst. “We have a nimbleness, which you don’t get at a university,” Chernoff told Nature. “But we little ships are in danger of sinking.”

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  2. Two Dozen House Republicans Do an About-Face on Tuition Tax
  3. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  4. The Biggest DNA Origami Structures Yet
    Daily News The Biggest DNA Origami Structures Yet

    Three new strategies for using DNA to generate large, self-assembling shapes create everything from a nanoscale teddy bear to a nanoscale Mona Lisa.